iBio Inc (IBIO):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:iBio Inc (IBIO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12099
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It has its applications in ibiolaunch platform, which is a transformative technology for the production of monoclonal antibodies, other therapeutic proteins and vaccines. iBio is developing therapeutic product for the treatment of idiopathic pulmonary fibrosis, systemic scleroderma and other fibrotic diseases, and others. The company’s IBIO-CFB03 is helpful for the treatment of idiopathic pulmonary fibrosis, fibrotic diseases and systemic sclerosis, among others. It collaborates with medical universities for its research and development activities. iBio is headquartered in New York, the US.

iBio Inc (IBIO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
iBio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
iBio Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
iBio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
iBio Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
iBio Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
iBio Inc, Medical Equipment, Deal Details 10
Partnerships 10
iBio Enters into Agreement with ONEWAY Diagnostica 10
iBio Enters into Agreement with TheoremDx 11
Equity Offering 12
iBio Raises USD16 Million in Public Offering of Shares 12
iBio Inc – Key Competitors 13
iBio Inc – Key Employees 14
iBio Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
iBio Inc, Medical Equipment, Key Facts, 2018 2
iBio Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
iBio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
iBio Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
iBio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
iBio Inc, Deals By Market, 2012 to YTD 2018 8
iBio Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
iBio Enters into Agreement with ONEWAY Diagnostica 10
iBio Enters into Agreement with TheoremDx 11
iBio Raises USD16 Million in Public Offering of Shares 12
iBio Inc, Key Competitors 13
iBio Inc, Key Employees 14
iBio Inc, Other Locations 15
iBio Inc, Subsidiaries 15

List of Figures
iBio Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
iBio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
iBio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
iBio Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
iBio Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
iBio Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
iBio Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
iBio Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[iBio Inc (IBIO):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Genome British Columbia:医療機器:M&Aディール及び事業提携情報
    Summary Genome British Columbia (Genome BC) is a non-profit medical research organization that conducts genomics and proteomics research, and offers science and technology solutions. The organization provides prognostic, new diagnostic, and therapeutic tools for use in personalized medicine. It also …
  • Determine Inc (DTRM):企業の財務・戦略的SWOT分析
    Summary Determine Inc (Determine), formerly Selectica Inc and a subsidiary of Corcentric, is a technology company. The company provides SaaS source-to-pay and enterprise contract lifecycle management solutions. It offers solutions such as strategic sourcing, supplier management; procure to pay, invo …
  • Akers Biosciences Inc (AKER):企業の製品パイプライン分析2018
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRO …
  • Kansas Electric Power Cooperative, Inc.:企業の戦略的SWOT分析
    Kansas Electric Power Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Argonaut Gold Inc.:企業の戦略・SWOT・財務情報
    Argonaut Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Argonaut Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • PG&E Corp:企業の発電所・SWOT分析2018
    PG&E Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executiv …
  • Thermal Energy International Inc (TMG):企業の財務・戦略的SWOT分析
    Summary Thermal Energy International Inc (Thermal Energy) is a cleantech company. The company supplies proprietary energy efficiency and emission reduction solutions to industrial and institutional sectors. Its products include GEM steam traps, FLU-ACE heat recovery systems, Dry Rex biomass dryer, a …
  • Luzerner Kantonalbank AG:企業の戦略・SWOT・財務分析
    Luzerner Kantonalbank AG - Strategy, SWOT and Corporate Finance Report Summary Luzerner Kantonalbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • OMV AG:企業の戦略・SWOT・財務情報
    OMV AG - Strategy, SWOT and Corporate Finance Report Summary OMV AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • RadNet Inc (RDNT):医療機器:M&Aディール及び事業提携情報
    Summary RadNet Inc (RadNet) is a radiology company which specializes in diagnostic imaging services. The company offers freestanding, fixed-site diagnostic imaging services including imaging procedures magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nu …
  • UCB S.A.:企業のM&A・事業提携・投資動向
    UCB S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's UCB S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • BoneSupport AB:企業の製品パイプライン分析
    Summary BoneSupport AB (BoneSupport), a subsidiary of Bonesupport Holding AB, is a orthobiologics company that develops, manufactures and markets injectable bioceramic bone graft substitutes for the treatment of fragility fractures caused by osteoporosis; bone voids and gaps caused by trauma; diseas …
  • Concord Medical Services Holdings Ltd (CCM):企業の財務・戦略的SWOT分析
    Summary Concord Medical Services Holdings Ltd (CMS) is a diagnostic imaging center that offers clinical support services and laboratory services. The center offers radiotherapy and diagnostic imaging equipment services such as head gamma knife systems, body gamma knife systems and linear accelerator …
  • Ridley USA Inc:企業の戦略的SWOT分析
    Ridley USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Legal & General Group Plc:企業の戦略・SWOT・財務情報
    Legal & General Group Plc - Strategy, SWOT and Corporate Finance Report Summary Legal & General Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • AXO Science SAS:企業の製品パイプライン分析2018
    Summary AXO Science SAS (AXO) is a developer of high output and multi-parametric analysis solutions for characterizing biological samples. The company offers solutions such as blood genotyping, allergy diagnosis, cancer diagnosis, pathogens detection, customized assays, sperm tracker, microarray spo …
  • Enphase Energy, Inc. (ENPH)-エネルギー分野:企業M&A・提携分析
    Summary Enphase Energy, Inc. (EEI), formerly PVI Solutions, Inc., is an energy management solutions provider that designs, develops, manufactures and sells microinverter system. Its semiconductor-based microinverter system converts direct current (DC) electricity to alternating current (AC) electric …
  • Mallinckrodt, LLC-製薬・医療分野:企業M&A・提携分析
    Summary Mallinckrodt LLC (Mallinckrodt), a subsidiary of Mallinckrodt Plc is a biophramaceutical company that develops medicines. The company manufactures, markets and distributes generic and specialty pharmaceuticals, active pharmaceutical ingredients, diagnostic imaging agents, global medical imag …
  • Dayton Superior Corp:企業の戦略的SWOT分析
    Dayton Superior Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • CalciMedica Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CalciMedica Inc (CalciMedica) is a pharmaceutical company that develops small molecule drugs for the treatment of acute and chronic inflammatory and autoimmune disorders and organ transplant rejection. The company’s CM2489 is a compound developed to treat moderate plaque psoriasis. It also i …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆